ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 680399 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 680399; 2) Community: the network communities that were significantly associated with the response to NSC 680399; 3) Molecule: the relationships between components within communities and NSC 680399; 4) MDR: the compounds that were significantly associated with the NSC 680399.

NSC Compound Enrichment Correlation
NSC 337581 ROYLEANONE-7A-FORMYLOXY-6B-HYDROXY-ERU 701 0.0284045326811616 0.0025899708
NSC 357704 Cyanomorpholinodoxorubicin 0.0284045326811616 0.14888322
NSC 606172 Camptothecin Derivative 0.0284045326811616 0.11870039
NSC 615035 Tetrazolium, 1-(4,5-dimethyl-2-thiazolyl)-2-phenyl-4-(4-pyridyl)-,bromide 0.0284045326811616 0.0032508664
NSC 633484 Null 0.0284045326811616 -0.16397137
NSC 637220 cis-Difluorobis(1-phenylhexane-1,3-dionato)titanium(IV) 0.0284045326811616 0.34823423
NSC 654893 Null 0.0284045326811616 0.13913441
NSC 681636 Camptothecin Derivative 0.0284045326811618 0.17074678
NSC 682763 Null 0.0284045326811618 0.46931275
NSC 700893 5H-Furo[3',2':4,5]furo[3,2-b]xanthen-5-one, 3a,12a-dihydro-3a,4,6-trihydroxy-9-(3-hydroxy-3-methylbutyl)-, (3aR,12aR)- (9CI) 0.0284045326811618 -0.21560954
Total:37  Current:18    [First] [Prev] [Next] [Last]